 1. To evaluate the magnitude of the antibody responses to one or two priming 0.5mL intramuscular IM doses of an MF59-adjuvanted AVietnam11942004 H5N1 Clade 1 influenza vaccine, each dose containing 7.5μg of H5N1 haemagglutinin, in immunologically naïve subjects; 